Prevalence of isolated systolic hypertension in the population over 55 years old. Results from a national study [1]

Revista Portuguesa de Cardiologia

Volumn 26, Issue 1, 2007, Pages 11-18

  Clara, J Gorjão ^a   De Macedo, Mário Espiga ^b   Pego, Mariano ^b  

^a HOSPITAL PULIDO VALENTE   (Portugal)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CLINICAL STUDY; CONTROLLED STUDY; DIAGNOSTIC PROCEDURE; FEMALE; HEALTH CENTER; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; ORTHOSTATIC HYPOTENSION; PREVALENCE; PULSE PRESSURE; RISK FACTOR; STANDARDIZATION; SYSTOLIC HYPERTENSION;

AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH SURVEYS; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PORTUGAL; PREVALENCE; SYSTOLE;

EID: 33947198347     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Nielsen WB, Vestbo J, Jensen GB. Isolated systolic hypertension as a major risk factor for stroke and myocardial infarction and an unexploited source of cardiovascular prevention: a prospective population-based study. J Hum Hypertens 1995; 9: 175-180.
2. Petrovitch H, Curb JD, Marcus EB. Isolated systolic hypertension and risk of stroke in Japanese-American men. Stroke 1995; 26: 25-29.
3. National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program Working Group report on hypertension in the elderly. Hypertension 1994; 23: 275-285.
4. Joint National Committee. The sixth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med 1997; 157: 2413-2446.
5. Dart A, Silagy C, Dewar E, Jennings C, McNeil J. Aortic distensibility and left ventricular structure and function in isolated systolic hypertension. Eur Heart J 1993: 14: 1465-1470.
6. Pasiersky T, Pearson AC, Labovitz AJ. Pathophysiology of isolated systolic hypertension in elderly patients: Doppler echocardiographic insights. Am Heart J 1991; 122: 528-534.
7. Berger DS, Li JK. Concurrent compliance reduction and increased peripheral resistance in the manifestation of isolated systolic hypertension. Am J Cardiol 1990; 65: 67-71.
8. Nichols WW, Nicolin FA; Pepino CJ. Determinants of isolated systolic hypertension in the elderly. J Hypertens 1992; 10 (suppl 6): S73-S77.
9. Borenstein J, Whyte JL, Badamgarav E, Vogel D, Deutsch S, Weingarten S, Lapuerta P. Physician practice patterns in the treatment of isolated systolic hypertension in a primary health care setting. J Clin Hypertens 2002; 4: 93-100.
10. Silagy CA, McNeil J. Epidemiologic aspects of isolated systolic hypertension and implications for future research. Am J Cardiol 1992; 69: 213-218.
11. Garland C, Barret-Connor E, Suarez L, Criqui MH. Isolated systolic hypertension and mortality after 60 years. A prospective population-based study. Am J Epidemiol 1983; 118: 365-376.
12. Kannel WB, Wolf PA, McGee D, Dawber TR, McNamara P, Castelli WP. Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. JAMA 1981; 245: 1225-1229.
13. Sagie A, Lanson MG, Levy D. The natural history of borderline isolated systolic hypertension. N Engl J Med 1993; 329: 1912-1917.
14. Van den Ban GC, Kampman E, Schouten EG, Kok FJ, Van der Heide RM, Van der Heide-Wessel C. Isolated systolic hypertension in Dutch middle aged and all-cause mortality: a 25-year prospective study. Int J Epidemiol 1989; 18: 95-99.
15. Rutan GH, Kuller LH, Neaton JD, Wentworth DN, McDonald RH, Smith WM. Mortality associated with diastolic hypertension and isolated systolic hypertension among men screened for the Multiple Risk Factor Intervention Trial. Circulation 1988; 77: 504-514.
16. Kannel WB, Castelli WP, McNamara PM. Role of blood pressure in the development of congestive heart failure: the Framingham Heart Study. N Engl J Med. 1972;287:781-787.
17. Goss LZ, Rosa RMF, O'Brien WM. Predicting death from renal failure in primary hypertension. Arch Intern Med. 1969;124:160-164.
18. Rationale and design of a randomised clinical trial prevention of stoke in isolated systolic hypertension. The Systolic Hypertension in the Elderly Program (SHEP) Cooperative Research Group. J Clin Epidemiol 1988; 41: 1197-1208.
19. Staessen JA, Fagard R, Thijs L, Celis H, Arabidze GG, Birkenhager WH, Bulpitt CJ, de Leeuw PW, Dollery CT, Fletcher AE, Forette F, Leonetti G, Nachev C, O'Brien ET, Rosenfeld J, Rodicio JL, Tuomilehto J, Zanchetti A. Randomised double-bund comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 1997; 350: 757-764.
20. The fifth report of the Joint National Committee on detection, evaluation, and treatment of High Blood Pressure (JNC V). Arch Intern Med 1993, 153:154.